Improving cancer therapy through national clinical trials.
NCI National Clinical Trials Network (UG1)
This study is all about improving cancer treatment by testing new ways to diagnose and treat different types of cancer, including rare ones, so that patients can benefit from the latest scientific discoveries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11251672 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer treatment by participating in the National Clinical Trials Network (NCTN) program. It aims to translate scientific discoveries from the laboratory to clinical settings, allowing for better diagnostics, imaging, and targeted therapies for cancer patients. By collaborating with various networks, the research seeks to lead and participate in clinical studies that address the needs of patients with different types of cancers, including rare forms. The program emphasizes community involvement and aims to improve patient outcomes through innovative cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with various types of cancer, particularly those who are 21 years or older.
Not a fit: Patients with non-cancerous conditions or those under 21 years old may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved patient outcomes.
How similar studies have performed: Previous research within the NCTN framework has shown success in improving cancer treatment outcomes, indicating that this approach is both tested and effective.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Thomas, Alexandra — Duke University
- Study coordinator: Thomas, Alexandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.